Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Collection of Donor Tissue and Whole Blood or Leukapheresis Product From Patients With Solid Tumours to Enable Development of Methods for the Manufacturing of Clonal Neoantigen T Cell Products (cNeT)

NCT03517917 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03517917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03517917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Collection of Donor Tissue and Whole Blood or Leukapheresis Product From Patients With Solid Tumours to Enable Development of Methods for the Manufacturing of Clonal Neoantigen T Cell Products (cNeT)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 8, 2018
Completion date
October 8, 2024
Enrollment
221 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor